Skip to content

Clinical trials

Hematologic Neoplasms trials in Finland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Neoplasms Country / region: Finland Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20071
20101
20181
20201
20212
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting4
Completed3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Faron Pharmaceuticals Ltd1
Helsinki University Central Hospital1
Lakefront Biotherapeutics NV1
Merck Sharp & Dohme LLC1
Miltenyi Biomedicine GmbH1
Novartis Pharmaceuticals1
Sanofi1
Tampere University Hospital1
medac GmbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Neoplasms9
Leukemia2
Anemia, Refractory, with Excess of Blasts1
Bone Marrow Diseases1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive1
Leukemia, Myeloid1
Leukemia, Myeloid, Acute1
Leukemia, Myelomonocytic, Chronic1
Lymphoma1
Lymphoma, Large B-Cell, Diffuse1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.